FIELD: bioengineering.
SUBSTANCE: new anticancer antibodies are suggested, they link with a human frizzled receptor. Besides new epitopes as the components of human frizzled receptors are identified, they are suitable targets for anticancer agents. Besides, the methods of the antibodies use for the inhibition of a signal path through Wnt and/or inhibition of the tumour growth. The suggested group of inventions can be used in medicine.
EFFECT: higher efficiency of the compositions use.
20 cl, 46 dwg, 15 tbl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| WNT ANTAGONISTS AND METHODS OF TREATING AND TESTING | 2011 |
|
RU2593947C2 |
| SELECTION OF CANCER PATIENTS FOR INTRODUCTION OF WNT SIGNAL INHIBITORS BASED ON RNF43 MUTATION STATUS | 2013 |
|
RU2636000C2 |
| ANTI-LRP6 ANTIBODIES | 2011 |
|
RU2587625C2 |
| METHODS FOR TREATING CANCER, INCLUDING TIGIT-BINDING AGENTS | 2017 |
|
RU2765410C2 |
| METHODS OF INHIBITING OCULAR ANGIOGENESIS | 2009 |
|
RU2530583C2 |
| ANTIBODY AGAINST CLAUDIN 18A2 AND APPLICATION THEREOF | 2017 |
|
RU2793445C2 |
| MONOCLONAL ANTIBODY AGAINST FZD10, ITS USE | 2017 |
|
RU2765431C2 |
| EXPRESSION OF NEW CELL MARKS | 2018 |
|
RU2796334C2 |
| TRANSGENIC GENETIC LABELS AND METHODS OF USING | 2015 |
|
RU2729112C2 |
| TRANSPOSASE POLYPEPTIDES AND USE THEREOF | 2016 |
|
RU2735700C2 |
